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Efficiency, Efficacy, and Power in the Implementation of a 
Medication Adherence Aid 
Roy Cherian, MHS; Urmimala Sarkar, MD, MPH; Elaine C. Khoong, MD, MS; Sara Ackerman, PhD, MPH; 
Gato Gourley, MSc; and Dean Schillinger, MD
ABSTRACT
Nonadherence to medication regimens is common, with approximately 50% of patients not taking their med-
ications as prescribed. The Universal Medication Schedule (UMS) is a set of standardized, evidence-based, and 
patient-centered instructions for pill-form medications that has demonstrated improvements in adherence 
by promoting patient comprehension. An urban, publicly funded, integrated health care system attempted 
to adopt UMS labeling but had limited success at its largest pilot site, which was a safety-net health care 
system’s outpatient pharmacy. To assess barriers to implementation, we engaged pharmacists at this site in 
group interviews. We thematically analyzed transcripts by integrating sociological work on standardization 
with grounded theory methodologies. In addition to lacking technological infrastructure, tensions among 
efficiency, efficacy, and effectiveness, and tension between individual/biomedical versus population health 
perspectives emerged as barriers to implementation. Additionally, we discovered that hierarchies of profes-
sional power impeded uptake. For successful implementation of evidence-based practices for vulnerable 
populations in resource-poor settings, efforts must anticipate and reconcile the tensions among conflict-
ing demands, professional hierarchies, and divergent orientations to patient care. [HLRP: Health Literacy 
Research and Practice. 2018;2(3):e128-e131.]
Medication nonadherence is common, with approximately 
50% of patients not taking their medications as prescribed 
(Sabate, 2003). Nonadherence not only diminishes the poten-
tial efficacy of treatment strategies, but can also contribute to 
adverse drug events (Bailey et al., 2011; Budnitz, Lovegrove, 
Shehab, & Richards, 2011; Steinman, Handler, Gurwitz, Schiff, 
& Covinsky, 2011). One cause of nonadherence is difficulty 
interpreting medication instructions (Bailey et al., 2011). 
Traditional medication instructions often omit specifications 
regarding timing, indication, and frequency (Tarn, Paterniti, 
Orosz, Tseng, & Wenger, 2013; Wolf et al., 2009) while employ-
ing technical terms (e.g., “subcutaneously”) that can cause con-
fusion among patients with limited health literacy (Bailey et al., 
2014; Davis et al., 2006; Fang, Machtinger, Wang, & Schillinger, 
2006). Additionally, medication instructions are not standard-
ized; a study showed that prescribers have 53 different ways of 
conveying “take 1 tablet a day” on pill bottles (Bailey, Persell, 
Jacobson, Parker, & Wolf, 2009).
One evidence-based approach to enhance the comprehen-
sibility of prescription instruction is the Universal Medica-
tion Schedule (UMS) (Wolf et al., 2009), a set of standardized, 
plain-language instructions (National Council for Prescription 
Drug Programs, 2013). Emerging evidence suggests that better 
comprehension translates into improved medication adher-
ence and clinical outcomes (Wolf et al., 2011). Although UMS 
improves comprehension rates across literacy levels, it most 
strongly benefits those with low literacy, limited English profi-
ciency, and complex medication regimens (Wolf et al., 2011). 
 In response to a regulation passed by California’s State 
Board of Pharmacy (2012) requiring pharmacies to dispense 
medications with patient-centered labeling, the San Francisco 
Health Network, an urban public delivery system, began an 
initiative in November 2015 requiring its publicly owned and 
operated pharmacies to dispense medications with UMS in-
structions (Wolf et al., 2011). The Ambulatory Safety CEnter 
for INnovaTion (ASCENT), funded by a National Institutes of 
Health grant (P30HS023558-01), led this effort.
OBJECTIVE
This article describes barriers to UMS implementation and 
strategies to promote future uptake at the largest implemen-
tation site—the Zuckerberg San Francisco General Hospital 
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outpatient pharmacy (OP)—where conversion rates were sub-
optimal (Table 1). 
METHODS 
Study Setting
The OP prepares and processes an average of 310 prescrip-
tions a day. Its staff is comprised of 10 pharmacists and 10 
pharmacy technicians. Prescribers include 749 physicians and 
nurse practitioners caring for patients at on-site primary care 
clinics and specialty clinics, as well as at off-site community 
primary and urgent care clinics. 
Participants and Procedures
We conducted group interviews with front-line pharma-
cists in April 2016 to understand perceptions of the UMS and 
inform them of its ongoing implementation. The University 
of California San Francisco’s Institutional Review Board ap-
proved this study. The research team provided the pharmacy 
supervisor with a flyer indicating the dates, times, and reason 
for the group interviews to share with pharmacists 1 week 
prior. 
At the focus group, the first author read the consent form 
aloud and solicited any clarifying questions before obtaining 
verbal consent. The research team did not collect any demo-
graphic data or identifying information from participants. We 
asked participants to reflect on how technological infrastruc-
ture affected implementation and how pharmacists envisioned 
the UMS’s impact on comprehension, adherence, and patient 
safety. The first group interview involved four clinical phar-
macists and one pharmacy graduate student, and the second 
interview involved two clinical pharmacists and one pharmacy 
student. Each group interview lasted 1 hour. Interviews were 
audio-recorded and transcribed. The study team de-identified 
the transcripts to ensure anonymity.
Analysis
The first author (R. C.) extracted excerpts from the tran-
scripts using Dedoose 7.5.9. He then categorized excerpts 
into themes using a grounded theory approach by (1) writing 
memos for each excerpt to distill their content, (2) using words 
and phrases present in the excerpts to derive a coding scheme 
(Charmaz, 2006; Glaser, 1992), and (3) grouping these codes 
into an emergent theoretical framework.  
KEY RESULTS 
Conflicting Demands
In both group interviews, pharmacists remarked upon the 
difficulty of reconciling UMS conversion with their current 
workflow: 
[W]e were just “Leaned” so they want efficiency. They want 
better turnaround time… Well in this department, we don’t actu-
ally type the labels, the technicians do. So by the time we get the or-
der, the technician’s making a big jump in assumption about what 
the scheduling should look like. So if we get it and the technician 
decided that well, it should be taken in the morning and maybe it’s 
something like Paxil which has a lot of side effects and stuff, and 
as you said, I exercise my clinical judgment. Well what happens? I 
mean, it’s a hard stop. Because now I’ve got to take everything that’s 
presented to me, I have to run it back, put it in the holding queue 
and have it redone and it [increases] the turnaround time.
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Because the health system was unable to modify the elec-
tronic health record to automate UMS instructions at the point 
of prescribing, they instead relied on pharmacy technicians 
manually converting instructions at dispensing. However, tech-
nicians often lacked the clinical judgment required to make 
these conversions, resulting in redundancies in the workflow. 
Clinical pharmacists pointed out the contradiction between 
the emphasis on efficiency related to reducing the time needed 
to dispense a prescribed medication and the time required for 
manual UMS conversion. Without an information technology 
system that could automatically convert instructions into the 
UMS in a way that aligned with clinical judgment, pharmacy 
staff felt they lacked the necessary resources to implement UMS 
efficiently and effectively.  
Professional Culture: Perceived Liability and Transgressing 
Authority
Institutional approval and mandates did not allay pharma-
cists’ concerns surrounding the legality of conversion, which 
emerged most strongly with regard to transferring prescrip-
tions to other pharmacies: 
Say we transfer a prescription over to another pharmacy… 
Now, is Walgreens really getting the original of what the doctor 
prescribed? Not really. Because you prescribed three times a day 
and we’re saying morning, lunch, and dinner. Is that really legal in 
a way?
The concern for medico-legal liability was intimately related 
to concerns of harming patients. Because UMS adoption is not 
yet widespread, pharmacists were concerned that UMS imple-
mentation at the OP might lead to patients receiving inconsis-
tent instructions, causing confusion and ultimately harm: 
Let’s say the patient goes to multiple pharmacies, and they get 
the medication from us saying morning, noon, and night. The next 
prescription they bring it to MOMS [mail order medications] Phar-
macy…and they just enter as what the doctor typed, three times a 
day. Now, the patient gets confused like, “Well, okay. How am I sup-
posed to take this now? I have different directions.”
Experiential knowledge of patients who have been confused 
with UMS instructions that contradicted or differed from long-
standing instructions heightened pharmacists’ fear and anxiety 
that UMS may do more harm than good. 
Despite institutional approval, professional hierarchies made 
pharmacists feel it necessary at times to consult with prescribing 
physicians before converting medication instructions into UMS. 
As with the concern for patient confusion and the risk for harm, 
the fear of transgressing physician’s authority was not hypotheti-
cal: 
One doctor called in a prescription for Lipitor, a statin, that under 
the UMS policy has to change everything to the evening, so I try to 
get the doctor on the phone to put it in the evening. I got yelled by 
the doctor saying, “Lipitor is one of the statins that doesn’t need to be 
taken in the evening.” 
Standardization Versus Individualization 
Drawing more from training in pharmacokinetic principles 
rather than the literature on UMS, pharmacists believed that tra-
ditional instructions will produce greater biochemical homeosta-
sis due to more uniform intervals between administration than 
the intervals that are indicated in the UMS. 
For us as pharmacists, when we go to school and say if a pill is 
supposed to be taken three times a day, and then you automatically 
are thinking about it should be spaced out every eight hours…be-
cause you studied the drug, how it is absorbed, or how you could [you 
know, metabolize] supposed ideally.  
Furthermore, pharmacists implied that population-level stan-
dardization is not appropriate for vulnerable populations whose 
daily lives are not simple or predictable. Pharmacists claim that 
patients in the “safety-net” health system lack the autonomy to 
administer medications according to the UMS, which assumes 
normative, or at the very least consistent, definitions of morning, 
midday, and evening. In contrasting the safety-net population to 
a more affluent population, the pharmacist said: 
The populations that we take care [of] here, with multiple comor-
bidities, lifestyles, and daily schedules, are so varied. My day could be 
somebody’s night if they work nights…you have to be able to incor-
porate each individual’s life schedule.
Pharmacists conveyed that interventions to improve adher-
ence should focus on tailoring medication schedules that accom-
modate individual patients’ structural vulnerabilities (e.g., food 
or housing insecurity). When acknowledging that physicians 
may not possess the requisite time to individually tailor instruc-
tions, pharmacists concluded that the variability and ambiguity 
of traditional instructions are actually more accommodating of 
the daily lives in vulnerable populations. 
TABLE 1
UMS Implementation Outcomes by Site
SFDPH Pharmacy Sites
Pre-
Implementation
Post-
Implementation
Behavioral health 0% (0/34) 94% (30/32)
Jail health 14% (11/80) 99% (85/86)
Skilled nursing facility 34% (54/158) 88% (541/612)
Outpatient pharmacy 23% (991/4,317) 23% (835/3,571)
 
Note. SFDPH = San Francisco Department of Public Health; UMS = Universal Medica-
tion Schedule.
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LIMITATIONS
We were unable to speak with pharmacy technicians. 
Based on pharmacists’ comments and the centrality of the 
pharmacy technician with respect to workflow, their exclu-
sion likely means that we have an incomplete picture of the 
barriers of UMS implementation. Similarly, we were unable 
to assess or report on patient perspectives of the UMS. In ad-
dition, because our focus was on the lowest-performing and 
highest-volume site, this article does not examine the facili-
tators that likely were present at the three other sites. Lastly, 
we cannot generalize these findings given the nature of the 
sampling and qualitative research methodology. 
CONCLUSIONS 
Due to the limited resources in the face of the demands for 
complex multidisciplinary care, health care in the safety-net 
system requires striking a balance among efficiency, efficacy, 
and population health. Doing so while integrating quality im-
provement initiatives within “leaned” workflows can be com-
plex, especially when technological infrastructure is lacking. 
Concerning UMS implementation at one health system’s OP, a 
lack of flexibility in professional roles, compounded by inade-
quate technological infrastructure, produced an environment 
lacking the agility to implement evidence-based practices in 
sites for which they were designed. With the exception of in-
adequate technological infrastructure, these group interviews 
revealed actionable barriers to application, such as step-wise 
implementation, active evaluation, and prescriber education 
and “buy-in.”
Since these interviews, implementation has become step-
wise to give pharmacy technicians the time to learn optimal 
administration times for categories of drugs, thereby aligning 
conversion with clinical judgment and reducing redundan-
cies. We are now conducting interviews with patients to assess 
how UMS instructions affect adherence and accuracy, which 
will shed light on pharmacists’ skepticism about standard-
ization. Lastly, after the group interviews, the Chief Medical 
Officer of the San Francisco Health Network sent a memo 
reminding prescribers of the conversion policy along with a 
survey to assess their perceptions of UMS. Although the re-
sponse rate was low (29.8%, n = 223), support for UMS was 
overwhelmingly positive, with only 4.5% disagreeing with the 
conversion of traditional instructions into UMS. 
Despite the evidence supporting the UMS and its poten-
tial impact on clinical outcomes for vulnerable populations, 
limitations in technological infrastructure and tensions in 
professional hierarchies as well as different definitions of and 
orientations to patient-centered care hindered local imple-
mentation. Future implementation efforts and research should 
actively evaluate UMS in local settings while being mindful of 
these potential barriers to promote uptake. 
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